Technology Resources, Inc.
↗West Chester, Pennsylvania, USA
Technology Resources, Inc. (TRI) is a boutique technical and regulatory consulting firm that provides comprehensive support to the pharmaceutical, biotechnology, and medical device industries. Founded in 1994, the company specializes in Chemistry, Manufacturing, and Controls (CMC), regulatory affairs, quality systems, and clinical operations. They assist clients ranging from virtual startups to large multinational corporations in navigating the complex path from drug discovery to commercialization.
The firm is known for its deep expertise in preparing and managing regulatory submissions, including Investigational New Drug (IND) applications, New Drug Applications (NDA), and Biologics License Applications (BLA). TRI also provides technical services such as process validation, analytical method development oversight, and GMP/GLP/GCP compliance auditing, acting as an extension of their clients' internal technical teams.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$10M
Founded:1994
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, mAb, Cell therapy, Gene therapy, Peptides
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various virtual biotech firms, Mid-sized pharmaceutical companies, Contract Manufacturing Organizations (CMOs)
COMPETITION
Position:Niche Player
Competitors:Halloran Consulting Group, Cardinal Health Regulatory Sciences, Parexel Consulting, ProPharma Group, Lachman Consultant Services
LEADERSHIP
Key Executives:
David Olson - President
Scientific Founders:David Olson
LINKS
Website:tech-res.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Technology Resources, Inc.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.